Press

YPOG, acting with two separate teams, has advised the shareholders Evotec SE and Venrock Healthcare Capital Partners in connection with the sale of the biotech company Tubulis to Gilead for a total consideration of up to USD 5 billion (including all earn-out payments).

YPOG has advised Codesphere on a cross-border "reverse flip" from the United States to Germany, establishing a new European holding structure with a Societas Europaea (SE) as the parent company. The SE will going forward serve as the holding company of the Codesphere Group and forms the...